Minimal Residual Disease (MRD) monitoring is a critical aspect of managing and treating B-Cell Chronic Lymphocytic Leukemia (B-CLL), a type of leukemia that affects the white blood cells and can lead to severe immune system weakening. MRD refers to the small number of cancer cells that can remain in the body after treatment and may […]











